{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:30:24Z","timestamp":1791833424361,"version":"4.3.4"},"reference-count":38,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2010,9,30]]},"DOI":"10.2217\/fon.10.111","type":"journal-article","created":{"date-parts":[[2010,10,4]],"date-time":"2010-10-04T16:18:17Z","timestamp":1286209097000},"page":"1387-1394","source":"Crossref","is-referenced-by-count":18,"title":["The Trifunctional Antibody Catumaxomab in Treatment of Malignant Ascites and Peritoneal Carcinomatosis"],"prefix":"10.1080","volume":"6","author":[{"given":"Michael A","family":"Str\u00f6hlein","sequence":"first","affiliation":[{"name":"Department of Abdominal, Vascular &amp; Transplant Surgery, Cologne-Merheim Medical Center, University of Witten\/Herdecke, Ostmerheimer Str. 200, 51109Cologne, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus M","family":"Heiss","sequence":"additional","affiliation":[{"name":"Department of Abdominal, Vascular &amp; Transplant Surgery, Cologne-Merheim Medical Center, University of Witten\/Herdecke, Ostmerheimer Str. 200, 51109Cologne, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2010,10,4]]},"reference":[{"key":"e_1_3_2_2_1_1","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(85)90305-0"},{"key":"e_1_3_2_2_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000197702.46394.16"},{"issue":"4","key":"e_1_3_2_2_3_1","first-page":"83","article-title":"Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer.","volume":"16","author":"Sugarbaker PH","year":"1989","unstructured":"Sugarbaker PH , CunliffeWJ, BelliveauJet al.: Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer.Semin. Oncol.16(4 Suppl. 6), 83\u201397 (1989).","journal-title":"Semin. Oncol."},{"key":"e_1_3_2_2_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.2002.02274.x"},{"key":"e_1_3_2_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0748-7983(96)80009-6"},{"key":"e_1_3_2_2_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O"},{"key":"e_1_3_2_2_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00104-007-1435-0"},{"key":"e_1_3_2_2_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19890115)63:2<364::AID-CNCR2820630228>3.0.CO;2-V"},{"key":"e_1_3_2_2_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.187"},{"key":"e_1_3_2_2_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.9285"},{"key":"e_1_3_2_2_11_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-1039-7"},{"key":"e_1_3_2_2_12_1","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2006.03.079"},{"key":"e_1_3_2_2_13_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.125.2.437"},{"key":"e_1_3_2_2_14_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-2182"},{"key":"e_1_3_2_2_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2003.08.026"},{"key":"e_1_3_2_2_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602924"},{"key":"e_1_3_2_2_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207610"},{"key":"e_1_3_2_2_18_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-0754"},{"key":"e_1_3_2_2_19_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2010.482098"},{"key":"e_1_3_2_2_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/256495a0"},{"key":"e_1_3_2_2_21_1","doi-asserted-by":"publisher","DOI":"10.1042\/bst0300507"},{"issue":"4","key":"e_1_3_2_2_22_1","first-page":"413","article-title":"Bispecific antibodies for polyclonal T-cell engagement.","volume":"5","author":"Baeuerle PA","year":"2003","unstructured":"Baeuerle PA , KuferP, LutterbuseR: Bispecific antibodies for polyclonal T-cell engagement.Curr. Opin. Mol. Ther.5(4), 413\u2013419 (2003).","journal-title":"Curr. Opin. Mol. Ther."},{"key":"e_1_3_2_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2008.11.014"},{"key":"e_1_3_2_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2004.03.006"},{"key":"e_1_3_2_2_25_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.155.1.219"},{"key":"e_1_3_2_2_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.12.4651.bloodjournal88124651"},{"key":"e_1_3_2_2_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.8.2526"},{"issue":"5","key":"e_1_3_2_2_28_1","first-page":"3499","article-title":"TNFa contributes to the antitumor activity of a bispecific, trifunctional antibody.","volume":"21","author":"Zeidler R","year":"2001","unstructured":"Zeidler R , MayerA, GiresOet al.: TNFa contributes to the antitumor activity of a bispecific, trifunctional antibody.Anticancer Res.21(5), 3499\u20133503 (2001).","journal-title":"Anticancer Res."},{"key":"e_1_3_2_2_29_1","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1237"},{"key":"e_1_3_2_2_30_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.163.3.1246"},{"key":"e_1_3_2_2_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-28-18"},{"key":"e_1_3_2_2_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21338"},{"key":"e_1_3_2_2_33_1","first-page":"483","article-title":"Immunotherapy of peritoneal carcinomatosis.","volume":"134","author":"Strohlein MA","year":"2007","unstructured":"Strohlein MA , HeissMM: Immunotherapy of peritoneal carcinomatosis.Cancer Treat. Res.134, 483\u2013491 (2007).","journal-title":"Cancer Treat. Res."},{"key":"e_1_3_2_2_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21165"},{"key":"e_1_3_2_2_35_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2769"},{"key":"e_1_3_2_2_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25423"},{"key":"e_1_3_2_2_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2010.03.001"},{"issue":"15","key":"e_1_3_2_2_38_1","article-title":"Elimination of cancer stem cells (CD133+\/EpCAM+) from malignant ascites by the trifunctional antibody catumaxomab: results from a pivotal Phase II\/III study.","volume":"27","author":"Lindhofer H","year":"2009","unstructured":"Lindhofer H , SchoberthA, PelsterD, HessJ, HeroldJ, J\u00e4gerM: Elimination of cancer stem cells (CD133+\/EpCAM+) from malignant ascites by the trifunctional antibody catumaxomab: results from a pivotal Phase II\/III study.J. Clin. Oncol.27(S15) (2009) (Abstract 3014).","journal-title":"J. Clin. Oncol."}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon.10.111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:42:29Z","timestamp":1719124949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon.10.111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,30]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9,30]]}},"alternative-id":["10.2217\/fon.10.111"],"URL":"https:\/\/doi.org\/10.2217\/fon.10.111","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,30]]}}}